Managing Dyslipidemia in Patients with Chronic Kidney Disease: Evidence-Based Guidance for Primary Care
Managing Dyslipidemia in Patients with Chronic Kidney Disease: Evidence-Based Guidance for Primary Care
Publication
Faculty
Based on a symposium presented at the Primary Care Cardiometabolic Risk Summit by Louis Kuritzky, MD and Michael Bloch, MD
Michael Bloch, MD
Medical Director, Risk Reduction Center
Co-Director, Vascular Institute
St. Mary’s Regional Medical Center
Reno, Nevada
Louis Kuritzky, MD
Clinical Assistant Professor
Family Medicine Residency Program
University of Florida
Gainesville, Florida
Intended Learners
This activity is designed for primary care providers, internists, general practitioners, nurses, nurse practitioners, physician assistants, registered dietitians, and other related healthcare professionals involved in the care of patients with chronic kidney disease (CKD) and dyslipidemia.
Learning Objectives
After completing this activity, participants should be able to:
- Discuss how the presence of CKD results in a meaningful increase in cardiovascular risk (CV) risk, including the clinical consequences of dyslipidemia
- Describe the disparate pathophysiologic underpinnings of CV risk in CKD populations as compared with other comorbidities
- Outline primary outcome findings from clinical lipid modulation trials for the safe and effective management of dyslipidemia with statins, combination therapies, and adjunctive agents in patients with CKD
- Identify strategies to enhance adherence to dyslipidemia therapy in patients with CKD
Activity Overview
This accredited supplement is available in print and PDF format.
To be eligible for documentation of credit, participants must read all supplement content, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
There is no fee associated with this activity.
Participants who have successfully completed the live or on-demand versions of this activity are not eligible to receive credit for this enduring material.
Release Date: December 1, 2012
Expiration Date: December 1, 2013
Estimated time to complete: 1 hour
For questions regarding this educational activity, please call 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
Accreditation
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME
NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
CNE
This continuing nursing education activity awards 1.0 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.
Nurse practitioners participating in this educational activity will earn an AMA PRA Category 1 CreditTM certificate of completion or ANCC contact hours through AANP's reciprocity agreements.
CPE for Dietitians
North American Center for Continuing Medical Education, LLC (NACCME) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1 continuing professional education unit (CPEU) for completion of this program. Level 3. CDR Accredited Provider # HM001.
Independent Clinical Reviewer: Daniel Weiner, MD, Assistant Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts
Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California
Medical writer: Deborah Neveleff contributed to the writing and editing of this supplement.
Planning Committee
The planning committee comprises George Bakris, MD, Michael Bloch, MD, Louis Kuritzky, MD, Susie Seaman, NP, Daniel Weiner, MD; Nick Lombardi, Deborah Neveleff, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Bakris: Grant/Research support—Forest Laboratories, Novartis; National clinical trial principal investigator studies—Metronic, Relapysa; Consultant—Abbott, US Food and Drug Administration, Eli Lilly, Johnson & Johnson, Sevier, Takeda; Promotional speakers bureau—Novartis, Takeda; Advisory boards—American Society of Hypertension, National Kidney Foundation; Journals—American Journal of Nephrology (Editor), Diabetes Care (Associate Editor), Nephrology Dialysis and Transplant (Associate Editor)
Dr. Bloch: Consultant—AstraZeneca, Takeda; Promotional speakers bureau—AstraZeneca, Boerhinger-Ingelheim, Diiachi-Sankyo, Liposcience, Takeda
Dr. Kuritzky: Scientific Advisor—Kowa
Ms. Seaman: Scientific advisor—Mölnlycke Health Care; Promotional speakers bureau—Mölnlycke
Dr. Weiner: Grant/Research support—Keryx; Scientific advisor—Takeda
Ms. Neveleff, Mr. Robbin, Mr. Savage, and Ms. Steuerman disclosed no relevant financial relationships with any commercial interests.
Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, Vertex Pharmaceuticals, Inc, ViroPharma, Inc.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed in the supplement.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2012 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Grant Support
Supported by an educational grant from Merck
